Why is colorectal cancer increasing in young adults like Gen Z?

While the exact causes are still being studied, factors like diet, gut bacteria changes, and environmental exposures are suspected contributors to the rise in young-onset colorectal cancer.

How do federal funding cuts affect cancer research?

Cuts to agencies like the NIH can halt critical studies, slow down the development of new treatments, and reduce hope for patients and survivors, as federal funding is vital for innovation.

What does the Colorectal Cancer Alliance do?

The Colorectal Cancer Alliance is a nonprofit organization that supports research, patient advocacy, and raises funds to combat colorectal cancer, especially in light of federal funding challenges.

Home / Health / Young Cancers Rise: Funding Cuts Threaten Cure Search

Young Cancers Rise: Funding Cuts Threaten Cure Search

21 Dec

•

Summary

Colorectal cancer incidence is rising in Gen Z, millennials, and Gen X.
Federal research funding faces significant cuts, jeopardizing cancer research.
Survivors highlight the critical need for research and hope in treatment.

Young Cancers Rise: Funding Cuts Threaten Cure Search

Colorectal cancer is increasingly affecting younger demographics, including Generation Z, millennials, and Generation X, who are more prone to developing the disease in their 30s and 40s. This worrying trend emerges as federal research budgets face substantial cuts, raising alarms among medical professionals and cancer advocates. The reduction in funding jeopardizes ongoing studies and the development of new treatments.

Historically, federal research has been a cornerstone for cancer breakthroughs, with organizations like the National Institutes of Health playing a pivotal role. However, recent fiscal actions have led to the cessation of numerous studies, including many focused on cancer research. This situation is viewed by many as an "attack against anyone who has ever loved someone with cancer."

Despite these challenges, the experiences of survivors underscore the importance of continued scientific advancement. Treatments have evolved, offering better outcomes than in previous decades, and emerging therapies hold significant promise. The hope for a cure and improved quality of life for future patients hinges on sustained investment in cancer research.